RS55696B1 - Farmaceutske smeše sa velikom dozom biotina - Google Patents

Farmaceutske smeše sa velikom dozom biotina

Info

Publication number
RS55696B1
RS55696B1 RS20170135A RSP20170135A RS55696B1 RS 55696 B1 RS55696 B1 RS 55696B1 RS 20170135 A RS20170135 A RS 20170135A RS P20170135 A RSP20170135 A RS P20170135A RS 55696 B1 RS55696 B1 RS 55696B1
Authority
RS
Serbia
Prior art keywords
biotine
pharmaceutical compositions
compositions strongly
dosed
strongly dosed
Prior art date
Application number
RS20170135A
Other languages
English (en)
Inventor
Frédéric Sedel
Agnès Bellanger
Original Assignee
Assist Publique - Hôpitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assist Publique - Hôpitaux De Paris filed Critical Assist Publique - Hôpitaux De Paris
Publication of RS55696B1 publication Critical patent/RS55696B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
RS20170135A 2010-04-06 2011-04-05 Farmaceutske smeše sa velikom dozom biotina RS55696B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1052589A FR2958166B1 (fr) 2010-04-06 2010-04-06 Compositions pharmaceutiques fortement dosees en biotine
EP11714252.1A EP2555771B1 (fr) 2010-04-06 2011-04-05 Compositions pharmaceutiques fortement dosees en biotine
PCT/EP2011/055273 WO2011124571A1 (fr) 2010-04-06 2011-04-05 Compositions pharmaceutiques fortement dosees en biotine

Publications (1)

Publication Number Publication Date
RS55696B1 true RS55696B1 (sr) 2017-07-31

Family

ID=42651240

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170135A RS55696B1 (sr) 2010-04-06 2011-04-05 Farmaceutske smeše sa velikom dozom biotina

Country Status (17)

Country Link
US (1) US20130084334A1 (sr)
EP (1) EP2555771B1 (sr)
CA (1) CA2795465C (sr)
CY (1) CY1118967T1 (sr)
DK (1) DK2555771T3 (sr)
ES (1) ES2613977T3 (sr)
FR (1) FR2958166B1 (sr)
HR (1) HRP20170172T1 (sr)
HU (1) HUE031767T2 (sr)
IL (1) IL222277B (sr)
LT (1) LT2555771T (sr)
PL (1) PL2555771T3 (sr)
PT (1) PT2555771T (sr)
RS (1) RS55696B1 (sr)
SI (1) SI2555771T1 (sr)
SM (1) SMT201700122B (sr)
WO (1) WO2011124571A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2993780B1 (fr) * 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque
CA2910717C (en) 2013-04-29 2021-01-26 Assistance Publique - Hopitaux De Paris Biotin for use in treating x-linked adrenoleukodystrophy
EP3072513A1 (en) 2015-03-26 2016-09-28 Medday Biotin for treating Amyotrophic lateral sclerosis
EP3275439A1 (en) 2016-07-29 2018-01-31 Medday Pharmaceuticals Method for treating hepatic encephalopathy
CN113827591B (zh) * 2021-11-09 2023-06-09 上海市肺科医院 生物素在制备治疗脓毒症药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0995448A (ja) * 1995-09-29 1997-04-08 Calpis Food Ind Co Ltd:The 血中ビオチン濃度の増加方法およびビオチン含有飲食品
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
WO2004017766A1 (en) * 2002-08-23 2004-03-04 Dsm Ip Assets B.V. Novel nutraceutical compositions comprising biotin
WO2004028523A1 (ja) * 2002-09-30 2004-04-08 Daiichi Pharmaceutical Co., Ltd. パンテチン含有粒状物
IL162288A0 (en) * 2004-06-01 2005-11-20 Future Products Man S A Compositions and methods for treating neurodegenerative disorders
US8609165B1 (en) * 2009-07-02 2013-12-17 E5 Llc Dietary supplement for optimizing glucose levels, increasing energy, and improving general health
FR2993780B1 (fr) * 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque

Also Published As

Publication number Publication date
US20130084334A1 (en) 2013-04-04
ES2613977T3 (es) 2017-05-29
PT2555771T (pt) 2017-01-17
SMT201700122B (it) 2017-03-08
SI2555771T1 (sl) 2017-03-31
FR2958166A1 (fr) 2011-10-07
EP2555771A1 (fr) 2013-02-13
CA2795465A1 (fr) 2011-10-13
LT2555771T (lt) 2017-04-10
DK2555771T3 (en) 2017-02-13
HRP20170172T1 (hr) 2017-04-07
PL2555771T3 (pl) 2017-07-31
IL222277B (en) 2018-06-28
CA2795465C (fr) 2018-10-30
IL222277A0 (en) 2012-12-31
EP2555771B1 (fr) 2016-11-23
HUE031767T2 (en) 2017-07-28
CY1118967T1 (el) 2018-01-10
WO2011124571A1 (fr) 2011-10-13
FR2958166B1 (fr) 2012-07-13

Similar Documents

Publication Publication Date Title
HK1246170A1 (zh) 藥物組合物
ZA201300458B (en) C-met-modulator pharmaceutical compositions
ZA201301766B (en) Pharmaceutical compositions
IL225457A0 (en) Pharmaceutical composition
ZA201300718B (en) Pharmaceutical compositions
ZA201207670B (en) Pharmaceutical compositions
GB201010453D0 (en) Pharmaceutical composition
ZA201303223B (en) Pharmaceutical compositions
HRP20170172T1 (hr) Farmaceutski pripravci s visokim doziranjem u biotinu
IL226554A (en) Medicinal preparations containing alisporiovir
ZA201303177B (en) Pharmaceutical compositions
IL221501A (en) Medicinal product containing miramistine
GB201001911D0 (en) Pharmaceutical composition
EP2560678A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA201303732B (en) Pharmaceutical compositions
GB201008590D0 (en) Pharmaceutical compositions